proteins; Chikungunya (CHIKV) p62-E1 (Voss et al., 2010) and hemagglutinin (HA) from influenza B (B/Florida/4/2006, BEI Resources). After blocking and washing steps, purified
IgG antibodies in PBS were tested at 16 µg/ml and seven consecutive 1:2 dilutions against HA and p62-E1, and at 4 µg/ml and seven consecutive 1:4 dilutions against HIV-1 gp140 proteins. Control antibodies, mGO53 (negative) (Wardemann et al., 2003) , and ED38 (high positive) (Meffre et al., 2004) were included in each experiment. After washings, the plates were revealed by incubation for 1 h with goat HRP-conjugated anti-human IgG antibodies (Immunology Jackson ImmunoReseach, 0.8 µg/ml final), and by adding 100 µl of HRP chromogenic substrate (ABTS solution, Euromedex) after washing steps. Optical densities were measured at 405nm (OD 405nm ), and background values given by incubation of PBS alone in coated wells were subtracted. Experiments were performed using HydroSpeed™ microplate washer and Sunrise™ microplate absorbance reader (Tecan). HEp-2 ELISAs were performed using the QUANTA Lite TM ANA ELISA Kit (Inova Diagnostics) following the manufacturer's instructions. To determine the ionic strength dependence of the antibodyantigen interactions, ELISAs were performed as described above but with IgG bNAbs at a final concentration of 1.67 or 6.7 nM in 10 mM HEPES pH 7.3 containing different concentrations of 5.55, 16.67, 50, 150, 450 , and 1350 mM. All ELISA experiments were performed with duplicate or triplicate.
SPR binding assay
All experiments were performed with a Biacore T100 (Biacore, Inc) in HBS-EP+ running buffer (Biacore, Inc) at 25ºC. Purified KLH (Sigma), CHIKV protein p62-E1 (Voss et al., 2010) and human mGO53 IgG (Wardemann et al., 2003) ligands at 250 µg/ml were immobilized on CM5 chips (Biacore, Inc.) by amine coupling at pH 4.5 resulting in an immobilization level of 15,000 RUs. For kinetic measurements on protein-derived chips, IgGs were injected through flow cells at 1 µM in HBS-EP+ running buffer (Biacore, Inc.) at flow rates of 40 µl/min with 3 min association and 5 min dissociation. The sensor surface was regenerated between each experiment with a 30 s injection of 10 mM glycine-HCl pH 2.5 at a flow rate of 50 µl/min.
Sensorgrams were obtained after subtraction of backgrounds (binding to control flow cells
and signal of the HBS-EP+ running buffer) using Biacore T100 Evaluation software.
Indirect Immunofluorescence
HIV-1 and control antibodies were analyzed by indirect immunofluorescence on HEp-2 cells (ANA HEp-2, BION Enterprises) and mouse tissues (NOVA Lite® ANA KSL (Mouse Kidney/Stomach/Liver), Inova Diagnostics) sections using FITC-conjugated anti-human IgG antibodies as the tracer according to the manufacturer' instructions. Sections were examined using the fluorescence microscope Axio Imager 2 (Zeiss) with ApoTome.2 system, and pictures were taken at magnification x 40 with 7000 ms-acquisition using ZEN imaging software (Zen 2.0 blue version, Zeiss) at the Imagopole platform (Institut Pasteur).
Western blotting
Protein extracts were prepared from cell pellets of freshly cultivated human laryngeal carcinoma HEp-2 cells (ATCC ® CCL-23 ™ ) and E. coli (DH10b, Life technologies) using RIPA buffer-based extraction method (Cell signaling technology). The final concentration of protein lysates was determined using Bradford reagent assay (Sigma). Proteins (17.5 µg total/well) were separated by SDS-PAGE with a NuPAGE® 4-12% Bis-Tris Gel (Invitrogen), and electrotransferred onto nitrocellulose membranes. The filters were then saturated for 2 h in PBS-0.05% Tween 20 (PBST)-5% dry milk, and incubated with human monoclonal antibodies (at 10, 20 and 30 µg/ml) in PBST-5% dry milk for 2 h. After washing with PBST, filters were incubated for 1 h with 1/25,000-diluted Alexa Fluor 680-conjugated donkey antihuman IgG (Jackson ImmunoReseach) in PBST-5% dry milk. Finally, membranes were washed, and examined with the Odyssey Infrared Imaging system (LI-COR Biosciences).
Flow cytometry binding assay
Virus stocks for YU-2b and transmitted-founder HIV-1 strains (CH058, CH077 and WITO;
NIH AIDS Reagent Program) were prepared by the transfection of 293T cells as previously described (Casartelli et al., 2010) . CEM-NKR-CCR5 cells (NIH AIDS Reagent Program) were infected with viral inocula adjusted to achieve 10-30% of Gag + cells at 48 h post infection.
Infected cells were incubated with IgG antibodies (at 0.1, 1 and 10 µg/ml) for 30 min at 37°C in staining buffer (PBS, 0.5% BSA, 2mM EDTA), washed, and incubated 30 min at 4°C with AF647-conjugated anti-human IgG antibodies (1:400 dilution; Life technologies). Cells were then fixed with 4% paraformaldehyde and stained for intra-cellular Gag as previously described (Bruel et al., 2016 
CHIKV neutralization assays
To assay for CHIKV neutralization, serially diluted IgG antibodies (at 50 µg/ml and 7 consecutive 1:4 dilutions) were incubated for 1 h at 37°C with recombinant Renilla luciferaseexpressing CHIKV (Henrik Gad et al., 2012 
SPR affinity and thermodynamic analyses
To measure the apparent affinity of HIV-1 bNAbs (IgG and Fabs) to KLH, YU-2 and ZM-96 gp140 trimers, CM5 chips (Biacore, Inc.) were immobilized by amine coupling to reach immobilization levels of 9,000 RUs and 300-500 RUs, respectively (Mouquet et al., 2010) . Thermodynamic parameters were determined using Eyring's analyses as previously described (Hadzhieva et al., 2017) . Briefly, kinetic rate constants obtained at distinct temperatures (10, 15, 20, 25, 30, 35°C) were used to build Arrhenius plots. The values of slopes of the Arrhenius plots were calculated by using a linear regression analysis in GraphPad Prism v.6 (GraphPad Prism Inc. USA) and substituting the slopes into the equation Ea = -slope × R, where the "slope" = ∂ln(k a/d ) /∂(1/T) and Ea is the activation energy. The changes in enthalpy, entropy and Gibbs free, characterizing the association and dissociation phases were estimated by using the equations:
where T is the temperature in Kelvin degrees, kʹ is the Boltzman constant and h is the Planck's constant. The equilibrium values of the thermodynamic parameters were calculated using the equations:
The equilibrium thermodynamic parameters were also calculated by using Van't Hoff equation. Activation and equilibrium thermodynamic parameters were determined at a reference temperature of 25°C (298.7 K).
Molecular dynamics simulation
Molecular dynamics simulations of the antibodies were performed with the AMBER v.12
Molecular Dynamics program suite (D.A. Case, 2012; D.A. Pearlman, 1995; R. SalomonFerrer, 2013) . Explicit solvent within a rectangular water box was added and the starting structures were energy-minimized by applying the steepest descent and conjugate gradient algorithm for 1000 steps each. During a heating phase, the temperature was gradually adjusted to 300 K. The molecular dynamics (MD) simulations with the program module SANDER were performed for the duration of 2 ns at constant pressure with a time step of 2 fs (using the SHAKE algorithm) and a cut-off of 8 Å. Coordinates were stored every 2 ps.
For analysis, data sets were selected every 2 ps. Root-mean-square (rms) values were calculated relative to the first coordinate set of the MD trajectory using the CPPTRAJ module v.13.10. Average rms values specified in the text were calculated for the 2 nd ns of the trajectory. As the IgH loop 101-114 in the available m66 structure was disordered, it was excluded from the rms analyses, which were run on residues 1-100 and 115-130 of IgH and 1-107 of IgL. Trajectories were visualized and figures were produced with VMD (Humphrey et al., 1996) .
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